Biopharmaceuticals

Introductory Knowledge of Intellectual Property in Life Sciences – The Essential Relationship Between Medicines and Patents

Vol. 7: Wait what? You can squash a patent? – How to Defeat Patents That Block Advances in Life Science Business-

2025.11.30
Last time, we discussed patent litigation. The most powerful counteraction when accused of patent infringement is to “squash the patent” — that is, to invalidate it. If the patent can be invalidated, the rights that … 黒澤伸行

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

2025.11.01
Unlike the United States—a country known for its litigious culture – Japan sees relatively few patent lawsuits. However, the situation is somewhat different in the life sciences sector. In May of this year, a high-profile p… 黒澤伸行

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

2025.09.30
This time, we are going to talk about generic drugs and biosimilars. These days in Japan we don't hear the word "zoro", but up until about 20 years ago, generic drugs were commonly referred to as "zoro." The word “zoro” stems … 黒澤伸行

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

2025.09.01
Last time, we discussed how to obtain a patent, following the process from application to obtaining a patent. I touched on the length of a patent term at the end. Do you remember how long a patent term was? The answer is 20… 黒澤伸行

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

2025.07.31
So far, we’ve explored the medicine classification and patents (Vol. 1), and the reasons why Medicines and Patents are inseparable (Vol. 2). In this volume, the spotlight fa… 黒澤伸行

Vol. 2: Wow! The success rate of drug development is shockingly low!

2025.07.01
In the previous volume, we discussed the types of pharmaceutical medicines and patents, so you will remember that “new drugs” are brand drugs under the category of ethical drugs… 黒澤伸行

Vol. 1: First, let’s talk about medicine classification and patents

2025.05.30
Most people understand that patents are important in the life sciences industry, including pharmaceuticals and biotechnology. However, many might feel that the complexities of patents make them difficult … 黒澤伸行

Promotional image for Québec featuring the fleur-de-lis symbol and a night view of downtown Montréal with the text “Incontournable Québec.”

Quebec Life Science Companies and Organizations to Exhibit at BioJapan 2025

2025.09.22
From October 8 (Wed) to 10 (Fri), 2025, ten life science companies and organizations from Quebec, Canada will visit Japan to participate in BioJapan 2025!Booth: B-111. This is a unique ... 黒澤伸行

Aerial view of Vazyme headquarters and surrounding research facilities.

Introducing Vazyme Biotech Co., Ltd.

2024.08.07
Vazyme Biotech Co., Ltd. is a global service provider specializing in the design, manufacturing, and applicat… 黒澤伸行

Avantor analytical team working in the laboratory

Introducing Avantor, Inc.

2024.08.07
Avantor, a Fortune 500 company, is a leading global provider of products and services for customers in the biopharma, healthcare, education and government, and advanced technologies and applie… 黒澤伸行